UNSPSC 51162356: Naproxen/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162356 Naproxen/pseudoephedrine is a Commodity code that in state and local procurement covers pharmaceutical products and medical supplies used in correctional facilities, public health agencies, and community health programs. The recent solicitations under this code reveal that state and local governments purchase a broader range of parenteral and emergency pharmaceutical products than the code name alone suggests — including intravenous solutions, parenteral nutrition preparations, naloxone, and drug deactivation systems for medical and public health use. The Washington State Department of Corrections and Seminole County, Florida represent the issuing-body mix: a state correctional agency and a county health authority, both procuring pharmaceutical and medical products to support incarcerated populations and community health initiatives. Contractors must meet stringent qualification requirements including state business licensure, background clearances, documented experience in pharmaceutical preparation and delivery, and significant insurance coverage (Commercial General Liability, Professional Liability, Business Automobile Liability, and Cyber Liability).

The code shows recent activity in Washington and Florida. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with a response deadline of October 7, 2026, for parenteral products and services to supply eight correctional facilities across the state, with pre-bid conference on September 23, 2026; DOC encourages participation from small businesses, minority-owned businesses, women-owned businesses, and veteran-owned businesses under Chapter 39.19 RCW, and anticipates awarding up to three contractors per region with a contract term running November 26, 2026 through June 30, 2030. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023; pricing is firm for two years with one-year renewal option. Both procurements require vendors to meet federal compliance standards and demonstrate capacity for reliable delivery and product management.